Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED

US

Last updated May 30, 2026

What MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED makes

The company produces in vitro diagnostic (IVD) kits for detecting SARS-CoV-2 antigens, including rapid fluorescent immunoassay tests and rapid immunochromatographic (ICT) tests designed for self-testing at home. These devices are intended for point-of-care use to identify active infections within minutes, supporting individual and community testing efforts.

The portfolio includes Class N devices, which are regulated under the FDA’s In Vitro Diagnostic Device regulations and listed in the FDA’s Unique Device Identifier (UDI) database. The company operates from the United States, adhering to U.S. regulatory requirements for diagnostic testing products.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Information

Country
US
Address
—
Website
2020dx.com
LinkedIn
—
Facebook
—
Phone
(844) 793-2020
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
860396703

Catalogue (4)

DeviceModel / ReferenceRegistriesClassStatus
PathoCatch MPF25
FDA UDI
NActive
CoviSelf MDSC01
FDA UDI
NActive
Gazelle PathoCatch MGPF25
FDA UDI
NActive
CoviSelf MDSC02
FDA UDI
NActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.